WebbMicroport Shanghai MicroPort EP MedTech Co., Ltd.… About Us HistoryLeadership TeamPurpose and ValuesCorporate Social ResponsibilityContactCompliance Healthcare … Webb31 jan. 2024 · In the reporting period, the Company recorded revenue of RMB 897 million, representing an increase of 30.95% as compared to the corresponding period of last year; the net profit attributable to shareholders of listed companies after deducting the losses of associated companies and equity incentives was RMB 383 million, representing an …
李进军 - Natural Person Shareholder - Shanghai MicroPort
WebbMicroPort CardioFlow Medtech Corporation微创心通医疗科技有限公司 (“本公司”)是一家中国医疗器械企业,专注于心脏瓣膜疾病领域的创新的经导管及手术解决方案的研发和商业化。 本公司拥有上海微创心通医疗科技有限公司(“上海心通”)等多家子公司(统称“心通医疗”或“本集团”)。 本集团自主研发的第一代经导管主动脉瓣植入(“TAVI”) 产品VitaFlow … WebbAbout MicroPort NeuroTech™ Founded in Shanghai in 2012, MicroPort NeuroTech Limited (“MicroPort NeuroTech™”, stock code: 02172.HK), a subsidiary of MicroPort Scientific … how do i get rid of ad choices
Microport MicroPort EP Listed on the SSE STAR Market
WebbThe operation was the first 5G remote joint replacement surgery conducted using a Chinese-developed surgical robot. The remote teams connected via MicroPort® MedBot’s 5G interconnectivity platform, which provided real-time high-definition audiovisual transmission throughout the surgery. Webb24 nov. 2024 · Shanghai, China – On October 20, Contact Force Sensing RF Ablation Catheter ("Contact Force Catheter"), in-house developed by Shanghai MicroPort EP MedTech Co., Ltd. ("MicroPort® EP"), was approved to enter the special Green-Path by China Food and Drug Administration ("CFDA"), which is rapid-track of review and … Webb31 aug. 2024 · Shanghai, China, 31 August 2024 – Shanghai MicroPort EP Medtech Co., Ltd. (688351.SH, “MicroPort EP” or the “Company”), a global medical device company in the field of electrophysiological interventional diagnosis and ablation therapy and a joint-stock company of MicroPort Scientific Corporation, today announced it has successfully listed … how do i get rid of ads